Brandes Investment Partners’s Eli Lilly LLY Stock Holding History

Brandes Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-107,025	Closed	-$7.78M	–	196
2015 Q1	$7.78M	Sell	107,025 -62,323	-37%	-$4.44M	0.11%	87
2014 Q4	$11.7M	Sell	169,348 -2,133,714	-93%	-$144M	0.16%	81
2014 Q3	$149M	Sell	2,303,062 -383,196	-14%	-$24.3M	1.98%	17
2014 Q2	$167M	Sell	2,686,258 -16,806	-0.6%	-$1M	2.02%	16
2014 Q1	$159M	Sell	2,703,064 -8,885	-0.3%	-$496K	2.01%	16
2013 Q4	$138M	Buy	2,711,949 +302,815	+13%	+$15.2M	1.71%	23
2013 Q3	$121M	Buy	2,409,134 +348,882	+17%	+$18.3M	1.56%	24
2013 Q2	$101M	Buy	+2,060,252	New	+$112M	1.27%	30

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Brandes Investment Partners's LLY Position: Q2 2015 in Review

Brandes Investment Partners sold out of Eli Lilly (LLY) in Q2 2015, closing a stake of 107,025 shares — an estimated $7.78M sold.

Brandes Investment Partners first reported a position in LLY in Q2 2013 and held it in 8 quarters. The position peaked at $167M in Q2 2014. 1,138 funds tracked by Wall St. Rank hold LLY as of Q2 2015.

Brandes Investment Partners reported no remaining Eli Lilly position as of Q2 2015 after selling out during the quarter.
Brandes Investment Partners sold 107,025 Eli Lilly shares in Q2 2015, an estimated $7.78M.
Brandes Investment Partners first reported a position in Eli Lilly in Q2 2013 and held it in 8 quarters.
Brandes Investment Partners's Eli Lilly position peaked at $167M in Q2 2014.
1,138 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2015.

Based on Brandes Investment Partners's 13F filing for Q2 2015, filed 10 Aug 2015.